Tegaserod maleate
Tegaserod maleate (SDZ-HTF-919) is a selective 5-HT4 receptor agonist developed by Novartis. It was previously approved for IBS with constipation but was withdrawn due to cardiovascular risk concerns. This compound remains a valuable research tool for studying serotonergic pathways in gastrointestinal motility and related in vitro and in vivo models.
Product Specifications
CAS Number
189188-57-6
Product Name Alternative
5-HT, 5HTReceptor, 5-hydroxytryptamine Receptor, 5HT Receptor, 5-HT Receptor, bowel, inhibit, irritable, SDZ-HTF 919, SDZ-HTF919, SDZ-HTF-919, HTF 919, HTF919, HTF-919, IBS, Inhibitor, Gastrointestinal, Serotonin Receptor, Sert (Sodium-dependent), syndrome, Tegaserod, Tegaserod maleate, Tegaserod Maleate
Field of Research
Cell Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:125 mg/mL (299.43 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.79 mM)
Smiles
C (=C\C (O) =O) \C (O) =O.C (=NNC (NCCCCC) =N) C=1C=2C (NC1) =CC=C (OC) C2
Molecular Formula
C20H27N5O5
Molecular Weight
417.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB0532-500 1x 500 µL
Cytokeratin 14 (KRT14/532), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 